Loading…
Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity
5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT...
Saved in:
Published in: | IUBMB life 2016-12, Vol.68 (12), p.985-993 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 993 |
container_issue | 12 |
container_start_page | 985 |
container_title | IUBMB life |
container_volume | 68 |
creator | Chen, Weihai Wang, Xiaqing Yan, Minmin Wang, Yan Xie, Shixue Li, Hong Li, Ming |
description | 5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT2C receptor agonists. The present study examined whether repeated activation of 5‐HT2C receptor with a highly selective 5‐HT2C receptor agonist MK212 would induce a long‐term change in its antipsychotic‐like activity (either a sensitization or tolerance) in the conditioned avoidance response and MK801‐induced hyperlocomotion tests. Sprague‐Dawley rats were first tested under the intraperitoneal (i.p.) treatment of MK212 (0.25, 0.5, 1.0 mg/kg) for 5 consecutive days. Three days later, when all rats were injected with a low dose of MK 212 (0.25 mg/kg) and tested for avoidance responding, rats that had been pretreated with 1.0 and 0.5 mg/kg MK212 made significantly fewer avoidance responses than those that had been treated with vehicle (0.9% saline). However, this past drug exposure‐induced group difference was not significant in the MK801‐induced hyperlocomotion test. Overall, results from this study suggest that repeated treatment of MK212 is capable of inducing a dose‐dependent sensitization of antipsychotic activity in conditioned avoidance response. The discrepancy in sensitization of MK212 in CAR and MK801‐induce hyperlocomotion may be related to the different mechanism underlying the effect of MK212 in these two tests. © 2016 IUBMB Life, 68(12):985–993, 2016 |
doi_str_mv | 10.1002/iub.1580 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1834996801</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1834996801</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3110-e31a13b73b950cc445a5007162828262bf42df5781b20781b89e00481180e6183</originalsourceid><addsrcrecordid>eNpd0c1KxDAQAOAgij-r4BNIwIuXaiZp2vSoi3-oCKLnkrZTzdJta5Oq1YuP4DP6JKbs6sEEMoF8DDMZQnaBHQJj_Mj02SFIxVbIJkgOQSQlrP7dQ7FBtqydMb9ilqyTDR7HSQwh2yQfd9iidlhQXcxNbazrtDNNTZuSyu_Pr6eh6Jq3wXVD67QHSPmU6sdmlPTmigOnbdcUfY6WamqxtsaZ90UKLEvM3ZhJ1860dsifGmdyqnNnXowbtslaqSuLO8s4IQ9np_fTi-D69vxyenwdtAKABShAg8hikSWS5XkYSi19IxBx5XfEszLkRSljBRln46kSZCxUAIphBEpMyMEir6_0uUfr0rmxOVaVrrHpbepJmCSRYuDp_j86a_qu9tV5FXollIq92luqPptjkbadmetuSH-_1YNgAV5NhcPfO7B0HFfqx5WO40ovH07GKH4A0d2G-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1844993887</pqid></control><display><type>article</type><title>Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Chen, Weihai ; Wang, Xiaqing ; Yan, Minmin ; Wang, Yan ; Xie, Shixue ; Li, Hong ; Li, Ming</creator><creatorcontrib>Chen, Weihai ; Wang, Xiaqing ; Yan, Minmin ; Wang, Yan ; Xie, Shixue ; Li, Hong ; Li, Ming</creatorcontrib><description>5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT2C receptor agonists. The present study examined whether repeated activation of 5‐HT2C receptor with a highly selective 5‐HT2C receptor agonist MK212 would induce a long‐term change in its antipsychotic‐like activity (either a sensitization or tolerance) in the conditioned avoidance response and MK801‐induced hyperlocomotion tests. Sprague‐Dawley rats were first tested under the intraperitoneal (i.p.) treatment of MK212 (0.25, 0.5, 1.0 mg/kg) for 5 consecutive days. Three days later, when all rats were injected with a low dose of MK 212 (0.25 mg/kg) and tested for avoidance responding, rats that had been pretreated with 1.0 and 0.5 mg/kg MK212 made significantly fewer avoidance responses than those that had been treated with vehicle (0.9% saline). However, this past drug exposure‐induced group difference was not significant in the MK801‐induced hyperlocomotion test. Overall, results from this study suggest that repeated treatment of MK212 is capable of inducing a dose‐dependent sensitization of antipsychotic activity in conditioned avoidance response. The discrepancy in sensitization of MK212 in CAR and MK801‐induce hyperlocomotion may be related to the different mechanism underlying the effect of MK212 in these two tests. © 2016 IUBMB Life, 68(12):985–993, 2016</description><identifier>ISSN: 1521-6543</identifier><identifier>EISSN: 1521-6551</identifier><identifier>DOI: 10.1002/iub.1580</identifier><identifier>PMID: 27797140</identifier><identifier>CODEN: IULIF8</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>5‐hydroxytryptamine 2C receptor ; Animals ; Antipsychotic Agents - administration & dosage ; antipsychotics ; Avoidance Learning ; conditioned avoidance response ; Conditioning (Psychology) - drug effects ; Dose-Response Relationship, Drug ; Drug Evaluation, Preclinical ; Male ; MK212 ; MK801‐induced hyperlocomotion ; Motor Activity - drug effects ; Pyrazines - administration & dosage ; Rats, Sprague-Dawley ; Serotonin Receptor Agonists - administration & dosage</subject><ispartof>IUBMB life, 2016-12, Vol.68 (12), p.985-993</ispartof><rights>2016 International Union of Biochemistry and Molecular Biology</rights><rights>2016 International Union of Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27797140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Weihai</creatorcontrib><creatorcontrib>Wang, Xiaqing</creatorcontrib><creatorcontrib>Yan, Minmin</creatorcontrib><creatorcontrib>Wang, Yan</creatorcontrib><creatorcontrib>Xie, Shixue</creatorcontrib><creatorcontrib>Li, Hong</creatorcontrib><creatorcontrib>Li, Ming</creatorcontrib><title>Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity</title><title>IUBMB life</title><addtitle>IUBMB Life</addtitle><description>5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT2C receptor agonists. The present study examined whether repeated activation of 5‐HT2C receptor with a highly selective 5‐HT2C receptor agonist MK212 would induce a long‐term change in its antipsychotic‐like activity (either a sensitization or tolerance) in the conditioned avoidance response and MK801‐induced hyperlocomotion tests. Sprague‐Dawley rats were first tested under the intraperitoneal (i.p.) treatment of MK212 (0.25, 0.5, 1.0 mg/kg) for 5 consecutive days. Three days later, when all rats were injected with a low dose of MK 212 (0.25 mg/kg) and tested for avoidance responding, rats that had been pretreated with 1.0 and 0.5 mg/kg MK212 made significantly fewer avoidance responses than those that had been treated with vehicle (0.9% saline). However, this past drug exposure‐induced group difference was not significant in the MK801‐induced hyperlocomotion test. Overall, results from this study suggest that repeated treatment of MK212 is capable of inducing a dose‐dependent sensitization of antipsychotic activity in conditioned avoidance response. The discrepancy in sensitization of MK212 in CAR and MK801‐induce hyperlocomotion may be related to the different mechanism underlying the effect of MK212 in these two tests. © 2016 IUBMB Life, 68(12):985–993, 2016</description><subject>5‐hydroxytryptamine 2C receptor</subject><subject>Animals</subject><subject>Antipsychotic Agents - administration & dosage</subject><subject>antipsychotics</subject><subject>Avoidance Learning</subject><subject>conditioned avoidance response</subject><subject>Conditioning (Psychology) - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Evaluation, Preclinical</subject><subject>Male</subject><subject>MK212</subject><subject>MK801‐induced hyperlocomotion</subject><subject>Motor Activity - drug effects</subject><subject>Pyrazines - administration & dosage</subject><subject>Rats, Sprague-Dawley</subject><subject>Serotonin Receptor Agonists - administration & dosage</subject><issn>1521-6543</issn><issn>1521-6551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpd0c1KxDAQAOAgij-r4BNIwIuXaiZp2vSoi3-oCKLnkrZTzdJta5Oq1YuP4DP6JKbs6sEEMoF8DDMZQnaBHQJj_Mj02SFIxVbIJkgOQSQlrP7dQ7FBtqydMb9ilqyTDR7HSQwh2yQfd9iidlhQXcxNbazrtDNNTZuSyu_Pr6eh6Jq3wXVD67QHSPmU6sdmlPTmigOnbdcUfY6WamqxtsaZ90UKLEvM3ZhJ1860dsifGmdyqnNnXowbtslaqSuLO8s4IQ9np_fTi-D69vxyenwdtAKABShAg8hikSWS5XkYSi19IxBx5XfEszLkRSljBRln46kSZCxUAIphBEpMyMEir6_0uUfr0rmxOVaVrrHpbepJmCSRYuDp_j86a_qu9tV5FXollIq92luqPptjkbadmetuSH-_1YNgAV5NhcPfO7B0HFfqx5WO40ovH07GKH4A0d2G-A</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Chen, Weihai</creator><creator>Wang, Xiaqing</creator><creator>Yan, Minmin</creator><creator>Wang, Yan</creator><creator>Xie, Shixue</creator><creator>Li, Hong</creator><creator>Li, Ming</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201612</creationdate><title>Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity</title><author>Chen, Weihai ; Wang, Xiaqing ; Yan, Minmin ; Wang, Yan ; Xie, Shixue ; Li, Hong ; Li, Ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3110-e31a13b73b950cc445a5007162828262bf42df5781b20781b89e00481180e6183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>5‐hydroxytryptamine 2C receptor</topic><topic>Animals</topic><topic>Antipsychotic Agents - administration & dosage</topic><topic>antipsychotics</topic><topic>Avoidance Learning</topic><topic>conditioned avoidance response</topic><topic>Conditioning (Psychology) - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Evaluation, Preclinical</topic><topic>Male</topic><topic>MK212</topic><topic>MK801‐induced hyperlocomotion</topic><topic>Motor Activity - drug effects</topic><topic>Pyrazines - administration & dosage</topic><topic>Rats, Sprague-Dawley</topic><topic>Serotonin Receptor Agonists - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Weihai</creatorcontrib><creatorcontrib>Wang, Xiaqing</creatorcontrib><creatorcontrib>Yan, Minmin</creatorcontrib><creatorcontrib>Wang, Yan</creatorcontrib><creatorcontrib>Xie, Shixue</creatorcontrib><creatorcontrib>Li, Hong</creatorcontrib><creatorcontrib>Li, Ming</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>IUBMB life</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Weihai</au><au>Wang, Xiaqing</au><au>Yan, Minmin</au><au>Wang, Yan</au><au>Xie, Shixue</au><au>Li, Hong</au><au>Li, Ming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity</atitle><jtitle>IUBMB life</jtitle><addtitle>IUBMB Life</addtitle><date>2016-12</date><risdate>2016</risdate><volume>68</volume><issue>12</issue><spage>985</spage><epage>993</epage><pages>985-993</pages><issn>1521-6543</issn><eissn>1521-6551</eissn><coden>IULIF8</coden><abstract>5‐Hydroxytryptamine 2C (5‐HT2C) receptor agonists have been suggested to possess an antipsychotic activity in several acute preclinical tests of antipsychotic drugs with low extra‐pyramidal side effect liability. However, little is known about the long‐term effect associated with chronic use of 5‐HT2C receptor agonists. The present study examined whether repeated activation of 5‐HT2C receptor with a highly selective 5‐HT2C receptor agonist MK212 would induce a long‐term change in its antipsychotic‐like activity (either a sensitization or tolerance) in the conditioned avoidance response and MK801‐induced hyperlocomotion tests. Sprague‐Dawley rats were first tested under the intraperitoneal (i.p.) treatment of MK212 (0.25, 0.5, 1.0 mg/kg) for 5 consecutive days. Three days later, when all rats were injected with a low dose of MK 212 (0.25 mg/kg) and tested for avoidance responding, rats that had been pretreated with 1.0 and 0.5 mg/kg MK212 made significantly fewer avoidance responses than those that had been treated with vehicle (0.9% saline). However, this past drug exposure‐induced group difference was not significant in the MK801‐induced hyperlocomotion test. Overall, results from this study suggest that repeated treatment of MK212 is capable of inducing a dose‐dependent sensitization of antipsychotic activity in conditioned avoidance response. The discrepancy in sensitization of MK212 in CAR and MK801‐induce hyperlocomotion may be related to the different mechanism underlying the effect of MK212 in these two tests. © 2016 IUBMB Life, 68(12):985–993, 2016</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27797140</pmid><doi>10.1002/iub.1580</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1521-6543 |
ispartof | IUBMB life, 2016-12, Vol.68 (12), p.985-993 |
issn | 1521-6543 1521-6551 |
language | eng |
recordid | cdi_proquest_miscellaneous_1834996801 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | 5‐hydroxytryptamine 2C receptor Animals Antipsychotic Agents - administration & dosage antipsychotics Avoidance Learning conditioned avoidance response Conditioning (Psychology) - drug effects Dose-Response Relationship, Drug Drug Evaluation, Preclinical Male MK212 MK801‐induced hyperlocomotion Motor Activity - drug effects Pyrazines - administration & dosage Rats, Sprague-Dawley Serotonin Receptor Agonists - administration & dosage |
title | Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T03%3A03%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Repeated%20administration%20of%205%E2%80%90hydroxytryptamine%202C%20agonist%20MK212%20produces%20a%20sensitization%20effect%20of%20antipsychotic%20activity&rft.jtitle=IUBMB%20life&rft.au=Chen,%20Weihai&rft.date=2016-12&rft.volume=68&rft.issue=12&rft.spage=985&rft.epage=993&rft.pages=985-993&rft.issn=1521-6543&rft.eissn=1521-6551&rft.coden=IULIF8&rft_id=info:doi/10.1002/iub.1580&rft_dat=%3Cproquest_pubme%3E1834996801%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3110-e31a13b73b950cc445a5007162828262bf42df5781b20781b89e00481180e6183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1844993887&rft_id=info:pmid/27797140&rfr_iscdi=true |